MedPath
PPB Approval

IMJUDO CONCENTRATE FOR SOLUTION FOR INFUSION 25MG/1.25ML

HK-68210

Prescription only Medicines

April 29, 2024

Company Information

Company Details

UNIT 1-3, 11/F, CHINA TAIPING FINANCE CENTRE, 18 KING WAH RD, NORTH POINT, HONG KONG

Active Ingredients

tremelimumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.